This e-learning course reviews the topic of radiopharmaceuticals and their use in metastatic castration-resistant prostate cancer.
International experts in the field of GU Oncology and Nuclear Medicine provide an overview of radiopharmaceuticals used in prostate cancer.
In this first episode the discussion covers:
- Key data related to radiopharmaceuticals.
- The mechanism of action of such treatments.
- Practical considerations related to treatment sequencing.
- General radiation safety.
We highly recommend the e-learning course for Episode 2 of this podcast to continue your learning, which focuses on theranostics with PSMA-targeted radiopharmaceuticals.
This course has been accredited by EACCME®. For every hour of learning completed on COR2ED Checkpoint you will be able to claim 1 ECMEC® if you pass the assessment quiz for each of the courses you take. The expected duration of this course is 30 minutes.